miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 28, 2026

ServiceNow Reports Fourth Quarter and Full-Year 2025 Financial Results; Board of Directors Authorizes Additional $5B for Share Repurchase Program

View original at finance.yahoo.com
ServiceNow Reports Fourth Quarter and Full-Year 2025 Financial Results; Board of Directors Authorizes Additional $5B for Share Repurchase Program ServiceNow exceeds guidance across all Q4 2025 topline growth and profitability metrics Subscription revenues of $3,466 million in Q4 2025, representing 21% year-over-year gr…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Recent strategic acquisitions create enormous new market opportunities and solidify ability to put AI to work securely across every corner of the enterprise

    80% confidence
  • Customers with greater than $5M ACV reached 603, approximately 20% year-over-year growth

    80% confidence
  • ServiceNow significantly beat Q4 expectations, accelerated net new business, and issued exceptional guidance for 2026

    80% confidence
  • Q4 was another strong quarter, concluding a remarkable year of AI innovation

    80% confidence
  • Transactions greater than $1M net new ACV reached 244, representing nearly 40% year-over-year growth

    80% confidence
  • Now Assist net new ACV more than doubled year-over-year in Q4 2025

    80% confidence
  • With consistent Rule of 55+ profile, there is no AI company in the enterprise better positioned for sustainable profitable revenue growth than ServiceNow

    80% confidence
  • ServiceNow had substantial growth in licensed users, workflows, and transactions on platform

    80% confidence
  • ServiceNow is building the AI control tower for business reinvention so enterprises can operate securely in an agentic AI world

    80% confidence
  • ServiceNow strategy with disciplined focus on margin expansion remains unchanged, but ambition is higher and confidence in sustained high organic growth has never been greater

    80% confidence
  • Armis acquisition expected to 3x+ security/risk market opportunity

    80% confidence

Data points we hold from this source

ServiceNow · long term debt1491 million_USD
ServiceNow · intangible assets1121 million_USD
ServiceNow · shares repurchased3.6 millions
ServiceNow · subscription gross margin non gaap82.5 percent
ServiceNow · current rpo yoy growth25 percent
ServiceNow · goodwill3578 million_USD
ServiceNow · total current liabilities10443 million_USD
ServiceNow · current rpo12850 million_USD
ServiceNow · rd expense773 million_USD
ServiceNow · remaining repurchase authorization1400 million_USD
ServiceNow · total revenue3568 million_USD
ServiceNow · total rpo28200 million_USD
ServiceNow · operating cash flow margin62.5 percent
ServiceNow · operating margin gaap12.5 percent
ServiceNow · operating margin non gaap31 percent
ServiceNow · stockholders equity12964 million_USD
ServiceNow · operating cash flow2238 million_USD
ServiceNow · net income gaap401 million_USD
ServiceNow · accounts receivable2627 million_USD
ServiceNow · free cash flow4636 million_USD
ServiceNow · eps diluted non gaap0.92 USD
ServiceNow · eps diluted gaap0.38 USD
ServiceNow · net income non gaap959 million_USD
ServiceNow · strategic investments1542 million_USD
ServiceNow · stock based compensation rd207 million_USD
ServiceNow · acquisition spending1084 million_USD
ServiceNow · marketable securities long term3771 million_USD
ServiceNow · cash and equivalents3726 million_USD
ServiceNow · marketable securities current2558 million_USD
ServiceNow · stock repurchases597 million_USD
ServiceNow · capex238 million_USD

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com